Measurement and Comparison of Organic Compound Concentrations in Plasma, Whole Blood, and Dried Blood Spot Samples by Stuart A. Batterman et al.
ORIGINAL RESEARCH
published: 21 April 2016
doi: 10.3389/fgene.2016.00064
Frontiers in Genetics | www.frontiersin.org 1 April 2016 | Volume 7 | Article 64
Edited by:
Douglas Mark Ruden,
Wayne State University, USA
Reviewed by:
Paul Stemmer,
Wayne State University, USA
Abdu Adem,
United Arab Emirates University, UAE
*Correspondence:
Stuart A. Batterman
stuartb@umich.edu
Specialty section:
This article was submitted to
Toxicogenomics,
a section of the journal
Frontiers in Genetics
Received: 03 February 2016
Accepted: 04 April 2016
Published: 21 April 2016
Citation:
Batterman SA, Chernyak S and
Su F-C (2016) Measurement and
Comparison of Organic Compound
Concentrations in Plasma, Whole
Blood, and Dried Blood Spot
Samples. Front. Genet. 7:64.
doi: 10.3389/fgene.2016.00064
Measurement and Comparison of
Organic Compound Concentrations
in Plasma, Whole Blood, and Dried
Blood Spot Samples
Stuart A. Batterman*, Sergey Chernyak and Feng-Chiao Su
Department of Environmental Health Sciences, University of Michigan, Ann Arbor, MI, USA
The preferred sampling medium for measuring human exposures of persistent organic
compounds (POPs) is blood, and relevant sample types include whole blood, plasma,
and dried blood spots (DBS). Because information regarding the performance and
comparability of measurements across these sample types is limited, it is difficult to
compare across studies. This study evaluates the performance of POP measurements
in plasma, whole blood and DBS, and presents the distribution coefficients needed
to convert concentrations among the three sample types. Blood samples were
collected from adult volunteers, along with demographic and smoking information, and
analyzed by GC/MS for organochlorine pesticides (OCPs), chlorinated hydrocarbons
(CHCs), polychlorinated biphenyls (PCBs), and brominated diphenyl ethers (PBDEs).
Regression models were used to evaluate the relationships between the sample
types and possible effects of personal covariates. Distribution coefficients also were
calculated using physically-based models. Across all compounds, concentrations in
plasma were consistently the highest; concentrations in whole blood and DBS samples
were comparable. Distribution coefficients for plasma to whole blood concentrations
ranged from 1.74 to 2.26 for pesticides/CHCs, averaged 1.69 ± 0.06 for the PCBs,
and averaged 1.65 ± 0.03 for the PBDEs. Regression models closely fit most
chemicals (R2 > 0.80), and whole blood and DBS samples generally showed very
good agreement. Distribution coefficients estimated using biologically-based models
were near one and did not explain the observed distribution. Among the study
population, median concentrations of several pesticides/CHCs and PBDEs exceeded
levels reported in the 2007–2008 National Health and Nutrition Examination Survey,
while levels of other OCPs and PBDEs were comparable or lower. Race and smoking
status appeared to slightly affect plasma/blood concentration ratios for several POPs.
The experimentally-determined distribution coefficients can be used to compare POP
exposures across studies using different types of blood-based matrices.
Keywords: persistent organic compounds, distribution coefficient, plasma, whole blood, dried blood spots
INTRODUCTION
The “gold standard” for assessing environmental exposures to chemicals uses biomonitoring
(Sexton et al., 2004), and blood and urine are themost commonly used biological matrices (Aylward
et al., 2014). Persistent organic compounds (POPs), e.g., organochlorine pesticides (OCPs) and
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polychlorinated biphenyls (PCBs), are preferentially measured in
blood for several reasons, including their long half-lives (ATSDR,
2000, 2002). Large scale programs monitoring POPs in blood
include the U.S. National Health and Nutrition Examination
Survey (NHANES), a nationally representative sample that
measured OCPs, PCBs and brominated flame retardants (BFRs)
levels in serum of adults from 2001 to 2008 (CDC, 2015a), and
the German Environmental Surveys, a nationwide population
sample that measured OCPs and PCBs in whole blood samples
in 1997–1999 and 2003–2006 (Becker et al., 2002; Schulz et al.,
2007). There are few if any examples of large biomarker studies
of infants and children. However, newborn screening programs
aimed at detecting genetic diseases that use dried blood spot
(DBS) samples can provide a valuable opportunity to track
exposures to environmental pollutants (Olney et al., 2006;
Olshan, 2007; Ma et al., 2014; CDC, 2015b). Although DBS
samples represent very small volumes of blood (approximately
50 µL per spot), this sampling technique has advantages of
simple and safe collection, transport and storage (Jones and
Golding, 2009; Lu et al., 2012; Ostler et al., 2014) that may make
DBS sampling particularly suitable for large-scale studies and
studies of newborns. In additional, some authorities archive these
samples, which gives the possibility of retrospective exposure
assessments. Environmental pollutants that have been detected
in DBSs include several trace metals as well as OCPs, PCBs, and
polybrominated diphenyl ethers (PBDEs) (Burse et al., 1997; Lu
et al., 2012; Batterman and Chernyak, 2014; Ma et al., 2014). The
comparability of methods that measure POPs in different blood
matrices, specifically plasma/serum, whole blood, and DBS, has
not been reported.
The objectives of this study are to present and evaluate
measurement methods for POPs in plasma, whole blood
and DBS samples, and to develop conversion or distribution
coefficients that can be used for comparisons among studies. An
experimental study using a convenience sample and a wide range
of POPs was conducted for these purposes.
MATERIALS AND METHODS
Participant Recruitment and Sample
Collection
A convenience sample of 21 adults was recruited using emails and
face-to-face conversations. Inclusion criteria included age greater
than 18 years, no underlying health condition or medication
use that might make participation risky, ability to provide
informed consent, and ability to understand and communicate
in English. All participants provided written informed consent.
Abbreviations: BFR, Brominated flame retardant; CDS, Certified calibration
standard; CHC, Chlorinated hydrocarbon; DBS, Dried blood spot; GC/MS,
Gas chromatograph/mass spectrometer; GOF, Goodness-of-fit; HCH,
Hexachlorocyclohexane; IDL, Instrumental detection limit; IS, Internal
standard; Kow, Octanol-water distribution coefficient; Kp/b, Plasma-whole
blood distribution coefficient; MTBE, Methyl-t-butyl ether; NHANES, National
Health and Nutrition Examination Survey; OCP, Organochlorine pesticide; PBDE,
Polybrominated diphenyl ether; PCB, Polychlorinated biphenyl; POP, Persistent
organic compound; QA, Quality assurance; QC, Quality control; SRM, Standard
reference material.
Study protocols were approved by the University of Michigan
Institutional Review Board (HUM00090791).
Each participant completed a short questionnaire inquiring
about their age, sex, education level, race, and smoking status.
Using standard procedures and a professional phlebotomist, each
participant provided 10–12 mL venous blood samples drawn
from the cubital vein. From this sample, 4 mL was placed into
an evacuated Na-heparin/EDTA tubes (4 mL tube, lavender top)
for whole blood samples, 6 mL was placed into an evacuated
sodium heparin (6 mL tube, green top) for plasma samples, and
10 DBSs were prepared using a 100 µL syringe to apply 50 µL
drops to a paper card (Whatman 903 Protein saver card, Sigma-
Aldrich, St. Louis, MO, USA), forming circles approximately
12 mm in diameter. DBS samples were labeled, allowed to dry,
placed in a paper envelope, and sealed in a polyethylene bag.
Green top tubes were centrifuged at 3000 RPM for 20 min to
produce approximately 4 mL of plasma. All sample types were
stored at −80◦C until chemical analysis, which was completed
within 3 weeks of sample collection.
Analyses and Quality Assurance
Blood samples were analyzed for 54 persistent organic
compounds: 19 organochlorine pesticides, 2 other chlorinated
hydrocarbons (CHCs), 12 polychlorinated biphenyls (PCBs), 20
brominated diphenyl ethers (PBDEs), and tetrabromobisphenol
A (TBBA) (Supplemental Table S1). The target compounds were
selected as they have been widely used, have long half-lives in
the environment and humans, and have been associated with
adverse health effects, e.g., cancer and neurological disorders
(ATSDR, 2000, 2002, 2004). These compounds have a range of
chemical structure and have been used as target compounds in
other projects.
Sample preparation and analysis procedures followed
Batterman and Chernyak (2014) and Schantz et al. (2013).
DBS punches (12 mm dia) and 1 mL subsamples of blood
and plasma were spiked with 15 µL of surrogate solution, and
sonicated for 20 min after adding 1 mL hydrochloric acid (6M),
and sonicated a second time for 20 min after adding 6 mL of
ethanol/isopropanol (1:1). Samples were extracted twice using 6
mL hexane/methyl-t-butyl ether (MTBE, 1:1). After rotating for
2 min, the organic layer was transferred to a new tube, with 4 mL
1% potassium chloride, and the sample was re-extracted with 3
mL hexane/MTBE (1:1). The organic layers were combined, and
the solvent volume was reduced to 1 mL under a gentle N2 flow.
Next, the concentrated sample was eluted through a sulfuric
acid/silica gel column (Akros Corp, 60–200 µm; 1 g silica/33%
H2SO
−
4 0.1 g pure silica). Plasma did not require this sulfuric
acid clean-up; identical results were obtained for plasma samples
with and without additional sulfuric acid clean-up. Analytes were
eluted from the column using 8 mL of a hexane/DCM mixture
(1:1), and evaporated under N2 to 0.5 mL. The final extract was
prepared by adding 0.5 mL n-nonane, and then evaporating
under N2 to a final volume of 250 µL.
Analyses used a gas chromatograph/mass spectrometer
(GC/MS; 6890/5973, Agilent Industries, Palo Alto, CA, USA), a
DB-5 column for separation (30 m, 0.25 mm dia., film thickness
0.25 µm; J&W Scientific, Folsom, CA, USA), and electron
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capture negative chemical ionization (NCI SIM) detection.
Helium was used as the carrier gas and methane as the mass
spectrometry reagent gas. The helium flow rate was 0.7 mL
min−1, pressure was 5.43 psi, and the average velocity was 31 cm
s−1. The injection syringe was 10 µL, and the injection volume
was 2 µL. Separate runs were used for pesticides and other
chlorinated hydrocarbons, tri- through octa-BFRs, nona- and
deca-BFRs, and PCBs; these required from 34.5 min (BFRs) to
69.5 min (pesticides). GC temperature programs andMS settings
were optimized for the three compound groups (Batterman and
Chernyak, 2014). For PCBs, the initial oven temperature setting
was 80◦C, which was held for 1 min, then ramped at 20◦C/min to
150◦C, then ramped at 2◦C/min to 250◦C, held for 4min, ramped
at 30◦C/min to 300◦C, and finally held for 6 min. For pesticides,
the initial temperature was 80◦C, held for 1 min, ramped at
20◦C/min to 150◦C, ramped at 2◦C/min to 250◦C, held for 4
min, ramped at 10◦C/min to 300◦C, and then held for 6 min. For
tetra- through octa-homologs of PBDEs, the temperature started
at 80◦C, held for 2 min, and then ramped at 10◦C/min to 300◦C.
For nona- and deca-homologs of PBDEs, the initial temperature
was 80◦C, held for 2min, ramped at 50◦C/min to 300◦C, and then
held for 55 min. Ions and retention times are presented elsewhere
(Batterman and Chernyak, 2014).
Calibration standards used certified materials (persistent
pesticides, PCB and PBDE calibration solutions, Cambridge
Isotope Laboratories, Tewksbury, MA, USA) prepared at
concentrations of 0.01 and 0.05 (for DBS), 0.1, 0.5, 1, 10, and
50 ng mL−1 (all sample types). This range was selected to
span the range expected in human samples. Sample replicates,
performed in all cases, were averaged. Other calibration protocols
are described elsewhere (Batterman and Chernyak, 2014).
Instrumental detection limits (IDLs) were defined as the
amount of analyte for which the signal-to-noise ratio of the
peak was equal to three, based on analyses of low concentration
samples. The IDLs were determined by preparing and analyzing
composite samples of plasma and whole blood (collected from
5 volunteers), and assuming a final extraction volume of 250
µL and plasma/serum volume of 1 mL. For plasma and whole
blood samples, IDLs for pesticides/CHCs, PCBs and BFRs ranged
from 5 to 30, 0.1 to 0.9, and 0.1 to 30 ng L−1, respectively. For
DBS samples, IDLs for pesticides, PCBs and BFRs were higher,
10–120, 0.8–22, and 8–200 ng L−1, respectively. These IDLs are
appropriate for the distribution coefficients derived for this study.
QA procedures are described in Batterman and Chernyak
(2014). In brief, a minimum of two (for plasma/blood) or three
(for DBS) replicates were analyzed; these had high agreement.
Internal standards (IS), quantified in each run, used labeled
mixtures. Each set of analyses used quality control (QC) samples
that were processed in parallel with samples to check drift
(standard solution ran at the beginning and end of each batch),
blank contamination (including laboratory and field blanks),
linearity, spike recovery, and accuracy using a standard reference
material (SRM 1957, Organic Contaminants in Non-Fortified
Human Serum, NIST, Gaithersburg MD, USA). Results were
accepted only when replicate values varied by less than 10%,
linearity defined by R2 exceeded 0.999, and measurements of
the SRM were within 20% of certified value. All spike recoveries
were in the range of 76–102%. Levels of blank contamination in
standards and in processing materials were below IDLs, although
trace levels of β-hexachlorocyclohexane, trans-chlordane, cis-
chlordane, trans-nonachlor, p,p’-DDE, PCBs-132/153, 138/163,
202, 180, and PBDEs-47 and 99 were found; these levels were well
below concentrations in actual samples by 15-fold for DDE, 600
to 6000-fold for other pesticides, 10–70-fold for PBDEs, 7-fold
for PCB-202, and 200–2000-fold for the other PCBs.
Data Analyses
Compounds detected in fewer than 25% of the samples above
IDL were excluded from further analysis (Supplemental Table
S1). Measurements below the IDL were replaced by ½ IDL.
Descriptive analyses, including central tendency and dispersion,
were calculated for the demographic and biomarker data. The
normality of measurements was evaluated using Kolmogorov-
Smirnov tests. Associations between pairs of biomarkers were
examined using Spearman rank-order correlations. Diagnostics
used to detect potential outliers included the use of scatterplots
between each sample types, and modified Bland-Altman plots. In
a few cases (described below), data points were removed when
measurements between the sample types showed significant
disagreements.
Biomarker levels were compared to levels reported in
NHANES 2007–2008, the latest US national-level study that
measured POPs. NHANES used pooled serum samples (n = 264
pooled samples), each based on contributions from 8 individuals
(CDC, 2015a). A total of 24 POPs were common to both
NHANES and this study, of which 16 had detection frequencies
exceeding 25%. Since NHANES used a weighted pooled-sample
design, appropriate sample weights were applied when estimating
concentrations. Differences in POP concentrations between this
study and NHANES were tested using t-tests (for weighted
samples) and Wilcoxon-Mann-Whitney tests.
Distribution Models
The experimental distribution coefficient for each POP was
estimated as the fitted coefficient (β) in linear models
that regressed concentrations in plasma (or blood) against
concentrations in whole blood, e.g., Kp/b is the expected ratio of
concentrations in plasma to those in blood. The goodness-of-fit
(GOF) was examined using R2 for models with intercepts, and
the estimated R2est for models without intercepts, where R
2
est = 1–
[(error sum of squares for without-intercept models)/(corrected
total sum of squares from with-intercept models)].
Theoretical estimate of distribution coefficients for each POP
were calculated using a physically-based model that accounted
for chemical solubility in lipid and water, as well as the lipid and
water content in plasma and whole blood (Poulin and Krishnan,
1995):
Kt,p/b =
(
SoNp + Sw0.7Pp + So0.3Pp + SwWp
)
/
(SoNb + Sw0.7Pb + So0.3Pb + SwWb) (1)
where So = solubility of chemical in n-octanol (mg L
−1), Np =
neutral lipid content of plasma, Sw = solubility of chemical
in water (mg L−1), Pp = phospholipid content of plasma
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(Phillips et al., 1989), Wp = water content of plasma (Faye and
Payne, 1986), Nb = neutral lipid content of blood (Poulin and
Krishnan, 1995), Pb= phospholipid content of blood (Poulin and
Krishnan, 1995), and Wb = water content of blood (Poulin and
Krishnan, 1995). The solubility in n-octanol was estimated as the
product of the chemical’s solubility in water and its octanol-water
distribution coefficient (Kow), both of which were obtained from
EPI Suite Version 4.11 (USEPA, 2015).
Possible effects of demographic and smoking variables on
distribution coefficients were investigated by regressing the ratio
of concentrations measured in plasma and whole blood (using
individual samples) against demographic and smoking variables.
Statistical analyses and model fitting were performed using
SAS 9.2 (SAS Institute, Cary, NC, USA).
RESULTS AND DISCUSSION
Descriptive Analyses and Data Cleaning
Participants averaged 48 years in age (range: 29–65 years; n= 21).
Slightly over half (57%, n = 12) were male, 76% (n = 16) were
white, and 67% (n = 14) had graduate degrees (Supplemental
Table S2). Most (76%, n = 16) were lifetime non-smokers; one
(5%) was a current smoker.
After reviewing the data, two observations were considered
outliers and were removed from further analysis to improve
reliability. Pentachlorobenzene and β-hexachlorocyclohexane (β-
HCH) each had a single outlier (Supplemental Figure S1), which
when removed increased the fit of the distribution models and
improved agreement with distribution coefficients of the other
pesticides. α-HCH had slightly lower fit (R2 = 0.76) than other
POPs, probably due to low detection frequencies in plasma (48%)
and whole blood (33%) samples, but no outliers were identified.
Of the 54 target compounds, detection frequencies exceeded
25% for 33 compounds in plasma, 32 compounds in whole
blood, and 14 compounds in DBS samples (Supplemental Table
S1). For all compounds, concentrations in plasma exceeded
levels in whole blood, and blood and DBS samples had
similar concentrations (Figure 1). The limited sample volume
of the DBS samples resulted in higher detection limits, which
limited the number of analytes that could be detected using
the GC/MS. Among pesticides/CHCs, β-HCH had the highest
median concentration (1243, 668, and 641 ng L−1 in plasma,
whole blood and DBS samples, respectively); PCB-118 was the
highest among PCBs (196, 104, and 95 ng L−1), and PBDE-47
was the highest among flame retardants (998, 593, and 546 ng
L−1). The concentration data fit normal distributions for 23 of the
compounds in plasma, 17 of the compounds in whole blood, and
8 of the compounds in DBS samples. Other statistics by sample
type are shown in Table 1.
Concentrations of POPs within a chemical group included
a number of compound pairs that were moderately or highly
correlated (Supplemental Table S3). Considering concentrations
in plasma, for example, one-fifth of pesticide/CHC pairs had
Spearman correlation coefficients from 0.44 to 0.74; the highest
correlations were between β-HCH and trans-chlordane (r =
0.74), and between cis-nonachlor and trans-nonachlor (r= 0.66).
PCB congeners showed the strongest correlation (most congener
pairs above 0.7) with the exception of pairs involving PCB-
110. Among the BFRs, PBDE-66, 85, 99, and 100 were highly
correlated, reflecting their common source in PBDE technical
mixtures. Across the chemical groups, a few pairs of POPs were
moderately correlated, either positively or negatively. Overall,
measurements of the different POP types across the volunteers
had only limited correlation, which is expected given their
different exposure sources, however, the sample size is too limited
to draw conclusions regarding possible explanatory factors.
Figure 2 compares our measurements of POPs in plasma
to levels in the NHANES 2007–2008, which are often used
as U.S. reference values (CDC, 2015a). For pesticides/CHCs
and considering medians, we found much higher levels of
hexachlorobenzene (600 vs. 63 ng L−1) and β-HCH (1243 vs.
21 ng L−1), lower levels of trans-nonachlor (46 vs. 101 ng L−1),
and comparable levels of p,p’-DDE (1130 vs. 1256 ng L−1).
Concentrations of most PCB congeners were similar, including
PCBs-132/153, 138/163, and 180 (p > 0.05 for Wilcoxon-Mann-
Whitney tests), although we had higher levels of PCB-118 and
lower levels of PCB-170/190. For the PBDEs, we found higher
concentrations than NHANES with the exception of PBDE-
153. Considering means, our samples differed from NHANES
for all POPs except for PCB-180 (p < 0.05; t-tests). Many
factors might explain these differences, including the 7 year
gap between the studies (2014 vs. 2007–2008) and temporal
trends in POP use; regional differences associated with POP
use, environmental concentrations and intake rates (e.g., due to
differences in POP fate and diets, particularly fish consumption);
differences in the study populations (e.g., small convenience
vs. race-sex-age matched samples); and differences in study
design (e.g., individual vs. pooled samples). These and potentially
other factors make it unlikely that our convenience sample was
representative of US adults or the NHANES measurements,
however, this should not affect measurement performance or
distribution results, discussed next.
Distribution Coefficients
Regression models with and without intercepts gave very similar
estimates of Kp/b. Results of models without intercepts are shown
in Table 2 (models using intercepts are shown in Supplemental
Table S4). The experimental values of Kp/b ranged from 1.74 to
2.26 for pesticides/CHCs, and averaged 1.69 ± 0.06 for PCBs,
1.65± 0.03 for PBDEs, and 1.75 for tetrabromobisphenol A. The
distribution coefficients did not vary by concentration as shown
by modified Bland-Altman plots (Supplemental Figure S2). The
coefficient of variation, which represents the variation among the
21 participants, was typically within 3%, and model fit was high
(R2 > 0.80) in most cases. Fit was especially high for BFRs (R2 >
0.91), reflecting the strong GC/MS response and good separation
of these compounds in all sample matrices.
The literature contains biomarker measurements from four
types of blood samples. Whole blood samples typically are
collected in tubes containing an anticoagulant (commonly
EDTA). DBS samples represent whole blood without EDTA
(or other) treatments. Serum samples (not analyzed in the
present study) are collected in (clean) tubes, allowed to clot
(coagulate) for 30–45 min at room temperature, centrifuged,
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FIGURE 1 | Box plots of POP concentrations in plasma, whole blood and dried blood spot (DBS) samples in this study. Shows 5th, 25th, 50th, 75th, and
95th percentiles and average. Red diamond: plasma; blue dot: whole blood; green triangle: DBS. β-HCH, beta-hexachlorocyclohexane; PCB, polychlorinated
biphenyl; TBBPa, tetrabromobisphenol A; PBDE, polybromodiphenyl ether.
and pipetted. (The cell fraction or pellet is typically discarded).
Plasma is obtained from blood collected in tubes containing an
anticoagulant; the sample is centrifuged as soon as practicable
following collection. Plasma, the liquid fraction above the denser
fraction (pellet), accounts for roughly half of the whole blood
weight.
Blood is a complex matrix containing cells (including
red blood cells or erythrocytes, 42–45% wt; white blood
cells or leukocytes, 7%; and platelets or thrombocytes), other
cellular material, lipids (including neutral lipids, 0.44%; and
phospholipids at 0.21%), clotting factor proteins, electrolytes,
glucose, nutrients, hormones, water, and other substances.
Lipophilic compounds, like most organochlorine compounds,
will be entirely or largely absorbed or adsorbed to the lipid and
protein components of blood, and thus concentrations in cellular
material is expected to be low. If the compound was present
only in plasma (or serum) and none was in the centrifuged
fraction, then plasma (serum) would have concentrations about
1.8 times higher whole blood (fraction = 1/non-plasma fraction;
assumed plasma weight fraction = 0.55). Experimental values of
Kp/b ranged from 1.58 (PBDEs) to 2.26 (chlordanes), suggesting
that plasma contains 67 (PBDEs) to 100% (chlordanes) of the
compound mass present in the blood sample (the plasma content
involved in partitioning was reduced from 55 to 45% to fit
experimental results). A formal distribution model is discussed
in the subsequent section.
Concentrations in DBS and whole blood samples had very
high agreement, e.g., DBS/whole blood ratios ranged from 0.99 to
1.18, and distribution coefficients did not vary from one for half
of the POPs (p < 0.05). Linearity was high (R2 > 0.90) for most
compounds, but somewhat lower for trans-nonachlor (R2= 0.63)
and PCB-118 (0.47), probably due to chromatographic issues
(these peaks were poorly separated). Given the greater precision
and higher detection frequency of measurements in whole blood
compared to DBS, the use of the plasma/whole blood distribution
coefficient is preferred over the plasma/DBS coefficient. Still, Kp/b
and Kp/d values did not differ in most cases, although the R
2 for
Kp/d models were lower. Again, trans-nonachlor and PCB-118
had lower fit (R2 = 0.50 and 0.51, respectively).
Overall, while we cannot determine whether our sample is
representative, we saw no effects due to concentration and only
minor effects of other factors (discussed below), increasing our
confidence in the distribution coefficients reported in Table 2.
Several studies using human blood, plasma, and serum have
shown comparable results, although each study typically focuses
on only a few compounds. A regression analysis showed that
concentrations in plasma were elevated over blood by a factor of
1.32 for PCB153 and 1.35 for total PCBs (Sandau et al., 2000);
perfluorinated chemicals, which can behave differently, showed
slightly lower ratios, about 1.2–1.4 (Kärrman et al., 2006); and a
ratio of 1.5 was shown for PBDE-209 between serum and whole
blood (Leslie et al., 2007).
Modeled Distribution Coefficients
Distribution coefficients Kt,p/b, estimated using Equation (1),
ranged from 1.048 to 1.058 and showed little variation across
the chemicals. All values were well below experimental results
(1.58 < Kp/b < 2.26; Supplemental Table S5). Predicted values
were near unity since the neutral lipid content and phospholipid
content of plasma and whole blood are similar. All of the
target POPs are highly lipophilic (Kow from 2 × 10
4 to 4 ×
108, Supplemental Table S5), and no relationship was seen
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FIGURE 2 | Box plots of POP concentrations in plasma in this study and NHANES 2007–2008. Shows 5th, 25th, 50th, 75th and 95th percentiles and average.
Average for the current study shown in dot for this study, and diamond for the NHANES 2007–2008; **p < 0.01 and *p < 0.05 for t-tests; ##p-value < 0.01 and
#p-value < 0.05 for Wilcoxon-Mann-Whitney tests. Sample size for this study was 21, and 264 (pooled samples) for NHANES. β-HCH, beta-hexachlorocyclohexane;
PCB, polychlorinated biphenyl; BFR, brominated flame retardant; TBBPA, tetrabromobisphenol A; PBDE, polybromodiphenyl ether.
between Kow and Kp/b and thus, despite the large range of
Kow, all of the POPs were sufficiently lipophilic to minimize
differences in the plasma/whole blood distribution by this
variable. Equation (1) was designed to estimate distribution
coefficients for various tissues and blood, reflecting solubility
differences between the two matrices (Poulin and Krishnan,
1995). Its key drivers, the neutral lipid and phospholipid
contents, can differ substantially between tissues and whole
blood and produce large differences. For example, considering
pentachlorobenzene and comparing liver and whole blood
compartments with neutral lipid contents of 0.0281 and 0.0044,
respectively; phospholipid contents of 0.0389 and 0.0021; and
water contents of 0.72 vs. 0.80 (Poulin and Krishnan, 1995), the
liver/whole blood distribution coefficient is 9.37, nearly 9-fold
higher than the plasma/whole blood distribution coefficient of
1.048. The higher levels of POPs observed in plasma suggest
that neither the phospholipid nor the neutral lipid contents
of blood and plasma govern the distribution of POPs. While
accounting for lipid and water content, Equation (1) does not
explain effects of protein binding, metabolic process of chemicals,
complex cellular matrices, and other factors that may explain
differences (Poulin and Krishnan, 1995). Thus, experimentally-
derived values of distribution coefficients should be used.
Effects of Demographics and Smoking
Status on Plasma-Blood Ratios of
Chemical Concentrations
Sex, race, and smoking status showed small effects on the
plasma/blood distribution of several chemicals (Table 3). Males
had higher Kp/b for p,p’-DDE and PBDE-153 (by 0.63± 0.20 and
0.31 ± 0.11, respectively). White participants had slightly lower
ratios for cis-nonachlor, PBDE-47 and 154 (0.12± 0.05 to 0.82±
0.38), and higher ratios for PCB-151, 118, 132/153, 175, 174,
202, 170/190, PBDE-66 and 100 (−0.33 ± 0.14 to −0.16 ± 0.08)
compared to other races (AfricanAmericans andAsians). Former
or current smokers had lower ratios for hexachlorobenzene,
PCB-151, 118 and 132/153 (−0.35 ± 0.14 to −0.16 ± 0.08),
and higher ratios for cis-chlordane and trans-nonachlor (0.52
± 0.20 and 0.42 ± 0.21, respectively). Even though effects
of demographic and smoking status variable appear genuine,
most differences were within 20% of the mean, suggesting
that impacts from demographic and smoking variables were
small.
Our analysis of demographic and smoking variables is
exploratory and has important limitations. First, the small
sample size provides little power to detect effects and does
not allow generalization. Second, multiple comparisons must
be considered given the five models run for the 32 POPs,
i.e., there is a 19% chance (1–0.954) that the null hypothesis
would be falsely rejected for each POP. Third, outliers and
measurements below detection limits could affect results,
e.g., PBDE-66 and 85 initially were associated with age,
however, the significance disappeared when measurements
below detection limits were removed (Supplemental
Figure S3).
Recommendations and Applications
Measurements of POPs in plasma and whole blood are
widely used and represent an exposure metric that integrates
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TABLE 2 | Experimental distribution coefficients for plasma, whole blood, and DBS samples (n = 21).
Chemicals y = plasma, x = whole blood y = plasma, x = DBS y = whole blood, x = DBS
R2 Coefficient R2 Coefficient R2 Coefficient
Estimate SE Estimate SE Estimate SE
Pesticides + CHC
Pentachlorobenzene 0.73 1.92 0.10 – – – – – –
α-HCH 0.76 1.83 0.13 – – – – – –
Hexachlorobenzene 0.96 1.74 0.03 0.93 1.80 0.05 0.99 1.04 0.01
β-HCH 1.00 1.82 0.02 0.97 1.87 0.02 0.99 1.03 0.01
Dachtal 0.94 1.77 0.06 – – – – – –
trans-Chlordane 0.89 2.26 0.06 – – – – – –
cis-Chlordane 0.93 2.13 0.07 – – – – – –
trans-Nonachlor 0.91 2.18 0.07 0.50 2.18 0.17 0.63 1.00 0.07
p,p’-DDE 0.96 1.82 0.05 0.93 1.87 0.07 0.95 1.02 0.03
cis-Nonachlor 0.80 2.01 0.08 – – – – – –
PCBs
PCB-110 0.86 1.63 0.03 – – – – – –
PCB-151 0.91 1.75 0.03 0.79 1.86 0.05 0.91 1.06 0.02
PCB-135/144 0.93 1.71 0.03 - - - - - -
PCB-118 0.91 1.76 0.03 0.51 2.08 0.10 0.47 1.18 0.06
PCB-132/153 0.95 1.72 0.03 0.94 1.78 0.03 1.00 1.04 0.00
PCB-138/163 0.96 1.65 0.02 0.93 1.67 0.03 0.99 1.01 0.01
PCB-175 0.91 1.69 0.04 – – – – – –
PCB-174 0.85 1.59 0.05 – – – – – –
PCB-202 0.88 1.74 0.05 – – – – – –
PCB-180 0.80 1.67 0.03 0.75 1.66 0.03 0.97 1.00 0.01
PCB-170/190 0.88 1.74 0.05 – – – – – –
PCB-198 0.80 1.58 0.05 – – – – – –
BFRs
TBBPa 1.00 1.75 0.01 0.89 1.82 0.06 0.90 1.04 0.04
PBDE-28 0.99 1.60 0.03 – – – – – –
PBDE-75 0.99 1.68 0.03 – – – – – –
PBDE-47 0.99 1.67 0.01 0.97 1.73 0.02 0.98 1.04 0.01
PBDE-66 1.00 1.67 0.01 – – – – – –
PBDE-100 1.00 1.66 0.01 0.95 1.64 0.04 0.96 0.99 0.02
PBDE-99 1.00 1.65 0.01 0.99 1.72 0.01 0.99 1.04 0.01
PBDE-85 1.00 1.66 0.01 – – – – – –
PBDE-154 0.91 1.66 0.04 0.89 1.71 0.05 1.00 1.03 0.01
PBDE-153 0.97 1.61 0.03 – – – – – –
Based on linear regression models without intercepts. R2 for the no-intercept model was estimated by 1-[(error sums of squares for without intercept models)/(corrected total sums
of squares from with intercept modes)]. DBS, dried blood spot; β-HCH, beta-hexachlorocyclohexane; PCB, polychlorinated biphenyl; BFR, brominated flame retardant; TBBPA,
tetrabromobisphenol A; PBDE, polybromodiphenyl ether; SE, standard error.
across exposure pathways and sources (Sexton et al., 2004;
Aylward et al., 2014). Concentrations in plasma exceed
levels in whole blood and DBS, but distribution coefficients
allow adjustment and comparison across studies and study
types (CDC, 2015a). Distribution coefficients estimated in the
current study allow comparisons across studies, including with
national norms. Theoretical predictions (using Equation 1)
did not fully account for differences in solubility of plasma
and whole blood, thus experimentally-derived distribution
coefficients should be used. For PCBs and PBDEs, the use
of the average experimentally-derived plasma/whole blood
coefficient should be suitable, while compound-specific values are
recommended for pesticides/CHCs and tetrabromobisphenol A.
The values reported in this study are reliable and have excellent
reproducibility.
Most earlier studies have utilized plasma samples for POP
biomarker analyses. While plasma requires the extra steps
of centrifuging and then pipetting the sample (or removing
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the pellet), somewhat less cleanup is required, and POP
concentrations are higher. However, many studies have been
conducted using whole blood, and some researchers prefer to
avoid the extra steps, logistical issues, and risks of contamination
involved in obtaining plasma (Angerer, 2006). DBS sampling
is receiving increased attention due to its ease and safety
of collection, transport and storage, and the development
of advanced analytical technology that permits quantitation
in very small samples. DBS sampling may be cost-effective
and suitable for large studies and longitudinal study designs
(Jones and Golding, 2009; Ostler et al., 2014). Obtaining
very low DBS detection limits is challenging given the very
small sample volume available; this might be addressed with
additional sample preconcentration, for example, using on-
line extraction and LC/MS-MS, a technique with the promise
of increasing throughput and sensitivity (Lu et al., 2012). In
addition, DBS and other sample types can involve important
concerns regarding storage stability and other issues that may
affect their utility, particularly for archived samples used for
retrospective exposure assessment (Batterman and Chernyak,
2014).
Strengths and Limitations
Distribution coefficients between plasma and whole blood were
estimated for a wide range of POPs, providing information that
can be used to compare POP measurements among different
blood-based sample types. Very similar sample preparation
and analytical methods were used for the three sample types,
and most results are consistent and precise. This study had
several limitations. Detection frequencies were low for several
POPs and some sample types. While three broad classes of
POPs were measured, there are many other compounds of
interest as biomarkers. The small convenience sample is not
representative of all populations, and the measured data may
not capture extreme values. The sample size is too limited
to provide robust estimates of factors that might affect the
variation of the distribution. Only linear relationships between
plasma, whole blood, and DBS samples were investigated,
but data (and theory) suggest these are warranted. Finally,
we did not evaluate other analytical methods that might
improve sensitivity, which is particularly important for the DBS
samples.
CONCLUSIONS
Experimentally-determined human whole blood/plasma
distribution coefficients Kp/b ranged from 1.74 to 2.26 for
pesticides/CHCs, averaged 1.69 ± 0.06 for PCBs, 1.65 ± 0.03
for PBDEs, and 1.75 for tetrabromobisphenol A. Participant sex,
race and smoking status had only minor effects on these results.
For most compounds, whole blood and DBS samples were very
similar, e.g., thus, Kb/d = 1. These coefficients provide useful
information for comparing POP exposure levels across studies
using different types of blood matrices. POP measurements in
DBS samples correlated closely to those in the other sample
types, however, the limited sample volume increased detection
limits and reduced the number of compounds that could be
detected in this sample type.
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